News
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $45 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
JP Morgan Reiterates Overweight on TG Therapeutics, Maintains $25 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
TG Therapeutics Inc Awarded $186,776,520 Contract From Department Of Veterans Affairs, NAC Pharmaceuticals For Pharmaceutical Preparation Manufacturing 6505--Anti CD20 Antibodies
17 Apr 24
News, Contracts
(TGTX) - Analyzing TG Therapeutics's Short Interest
13 Mar 24
Short Sellers, Short Ideas, Trading Ideas
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $45 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $13
29 Feb 24
News, Price Target, Analyst Ratings
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
28 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today?
28 Feb 24
Biotech, Earnings, News, Guidance, Health Care, Movers, Trading Ideas, General
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $45 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
28 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Earnings Scheduled For February 28, 2024
28 Feb 24
Earnings
Earnings Preview For TG Therapeutics
27 Feb 24
Earnings
10 Health Care Stocks With Whale Alerts In Today's Session
26 Feb 24
Options
How Is The Market Feeling About TG Therapeutics?
16 Feb 24
Short Sellers, Short Ideas, Trading Ideas
Precision Biosciences Received An Initial $7.5M Upfront Cash Payment And Equity Investment From TG Therapeutics For An Exclusive License To Develop Azercabtagene Zapreleucel For Autoimmune Diseases And Other Indications Outside Of Cancer
12 Feb 24
Biotech, News, Health Care, Financing, Contracts, General
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $29-Report Released on 2 February 2024
5 Feb 24
News, Price Target, Analyst Ratings
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $29
5 Feb 24
News, Price Target, Analyst Ratings
Press releases
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
18 Apr 24
Press Releases
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
15 Apr 24
News, Health Care, Press Releases
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
27 Mar 24
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
8 Mar 24
News, Health Care, Press Releases
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
1 Mar 24
Press Releases
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
28 Feb 24
Earnings, Press Releases
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
27 Feb 24
News, Legal, Press Releases
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
23 Feb 24
News, Press Releases
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
12 Feb 24
Press Releases